Personalized Medicine News and Research RSS Feed - Personalized Medicine News and Research

InformedDNA reaches $4.5 million funding agreement with Zaffre Investments

InformedDNA reaches $4.5 million funding agreement with Zaffre Investments

InformedDNA, a leading provider of Genetic Benefits Management and the largest independent network of genetic specialists in the U.S., announced today that it has reached a $4.5 million funding agreement with Zaffre Investments, a wholly owned subsidiary of Blue Cross Blue Shield of Massachusetts. [More]
Johns Hopkins Medicine, Kaiser Permanente partner to expand ways to deliver quality care

Johns Hopkins Medicine, Kaiser Permanente partner to expand ways to deliver quality care

Kaiser Permanente and Johns Hopkins Medicine today announced plans to strengthen the successful collaboration between the two health care organizations. [More]
Cloud Pharmaceuticals awarded Phase I grant from NSF SBIR program

Cloud Pharmaceuticals awarded Phase I grant from NSF SBIR program

Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, announced today that it has been awarded a Phase I grant from the National Science Foundation Small Business Innovation Research program. [More]
More than half the world’s population is host to newly described gut virus

More than half the world’s population is host to newly described gut virus

Odds are, there-s a virus living inside your gut that has gone undetected by scientists for decades. A new study led by researchers at San Diego State University has found that more than half the world-s population is host to a newly described virus, named crAssphage, which infects one of the most common types of gut bacteria, Bacteroidetes. [More]

EndoControl wins 'World Innovation Challenge' award for ARCC project

EndoControl, a leading innovator of robot-assisted systems for endoscopic surgery, today announces that its CEO Clement Vidal has won an award in the 'World Innovation Challenge' for his ARCC project (Robot-assisted Co-Manipulation in Surgery) in the 'personalized medicine' category. [More]
EKF Diagnostics to highlight expanding product portfolio at AACC Clinical Lab Expo

EKF Diagnostics to highlight expanding product portfolio at AACC Clinical Lab Expo

EKF Diagnostics, the global diagnostics company, will be highlighting its expanding product portfolio on its subsidiary Stanbio Laboratory’s booth #1933 at the AACC Clinical Lab Expo in Chicago, USA, July 29-31. In addition to demonstrating success of current products, including Stanbio’s ß-HB assay technology and EKF Molecular’s PointMan technology, new products will be introduced at AACC. [More]
VCU awarded $3 million grant to study how childhood adverse experiences create long-term health risks

VCU awarded $3 million grant to study how childhood adverse experiences create long-term health risks

Virginia Commonwealth University has received a five-year, $3 million grant to study how adverse experiences such as severe illnesses, neglect and maltreatment during childhood leave molecular marks in DNA that predict health risks later in life. [More]
The Institutional Biobank of Lausanne invests in 2D sample storage consumables from Micronic

The Institutional Biobank of Lausanne invests in 2D sample storage consumables from Micronic

To support genomic clinical research, being undertaken to prepare the local area for personalized medicine, the Institutional Biobank of Lausanne (Lausanne, Switzerland) has invested in 2D sample storage consumables from Micronic to safeguard its valuable samples. [More]
New York State DOH grants RPCI approval to begin genomic testing of cancer patients

New York State DOH grants RPCI approval to begin genomic testing of cancer patients

The New York State Department of Health (DOH) has granted Roswell Park Cancer Institute (RPCI) approval to begin genomic testing of cancer patients using its OmniSeq TargetTM advanced molecular diagnostic laboratory test. [More]
Personalized medicine for breast cancer patients may be just around the corner

Personalized medicine for breast cancer patients may be just around the corner

For breast cancer patients, the era of personalized medicine may be just around the corner, thanks to recent advances by USC Stem Cell researcher Min Yu and scientists at Massachusetts General Hospital and Harvard Medical School. [More]
Advanced Cell Diagnostics’ in situ hybridization technology reaches two major milestones

Advanced Cell Diagnostics’ in situ hybridization technology reaches two major milestones

Advanced Cell Diagnostics Inc. (ACD), a leader in the field of molecular pathology and developer of cell and tissue-based analysis tools, has announced that its RNAscope® RNA in situ hybridization technology has reached two major milestones. In just three years, over 100 peer-reviewed papers featuring the technology have been published, and with the significant increase in use of RNAscope, ACD has now built a library of over 4000 target probes for numerous species. Probes are designed to order in under two weeks, and in just six months the library has grown by over 1500, reflecting the wide interest in ACD’s breakthrough technology. [More]
Researchers develop new software to identify severity of cancer

Researchers develop new software to identify severity of cancer

Together with the company Tissuegnostics, the pathologist Lukas Kenner and his colleagues have developed a software that is able to identify cancer cells in tissue sections and demonstrate the presence of specific biomarkers on cells. The overall information provides a precise picture of the disease and leads to the most suitable treatment. [More]
New approach for developing personalized gene therapies to treat retinitis pigmentosa

New approach for developing personalized gene therapies to treat retinitis pigmentosa

Columbia University Medical Center researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa (RP), a leading cause of vision loss. [More]
New diagnostic procedure helps differentiate psoriasis from eczema

New diagnostic procedure helps differentiate psoriasis from eczema

In some patients, the chronic inflammatory skin diseases psoriasis* and eczema** are similar in appearance. Up to now, dermatologists have therefore had to base their decision on which treatment should be selected on their own experience and an examination of tissue samples. [More]
Pseudogenes may play key role in the discovery of new biomarkers

Pseudogenes may play key role in the discovery of new biomarkers

Dysfunctional, unloved and seemingly of little use, these poor-cousin relatives of genes have lost their protein-coding abilities. They contain material not essential for an organism's survival and are the "last stop" for removal of genomic waste. [More]
AutoGenomics, Genomas sign agreement to develop DNA-guided diagnostic systems

AutoGenomics, Genomas sign agreement to develop DNA-guided diagnostic systems

AutoGenomics, Inc, a leader in automated microarray technology for molecular diagnostics, and Genomas, a biomedical company enabling DNA-guided medicine for personal healthcare, announced today that they have signed an agreement to jointly develop genetic tests and DNA-guided diagnostic systems for optimal selection of statins and for improved delivery of statin therapy for the treatment of cardiovascular disease, obesity and diabetes. [More]
New collaborative fundraising effort focuses on AYA cancer

New collaborative fundraising effort focuses on AYA cancer

Leaders from Case Western Reserve University and University Hospitals this evening announced a new collaborative fundraising effort focused on Adolescent and Young Adult (AYA) cancer. [More]
Researchers give new, unprecedented 3-D view of most important brain receptors

Researchers give new, unprecedented 3-D view of most important brain receptors

Researchers with Oregon Health & Science University's Vollum Institute have given science a new and unprecedented 3-D view of one of the most important receptors in the brain - a receptor that allows us to learn and remember, and whose dysfunction is involved in a wide range of neurological diseases and conditions, including Alzheimer's, Parkinson's, schizophrenia and depression. [More]
Key historical misconceptions hinder research and treatment for brain metastases

Key historical misconceptions hinder research and treatment for brain metastases

"Key historical misconceptions" are hindering progress in research and treatment for patients with cancer metastases to the brain, suggests a special article in the July issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. [More]
Definiens closes €15M financing round to expand into digital tissue diagnostics

Definiens closes €15M financing round to expand into digital tissue diagnostics

Definiens AG, which offers a unique approach to tissue diagnostics aimed at helping physicians improve treatment, said that it has closed a round of financing for € 15 million. [More]